Novartis provides update on CAN-COVID trial in hospitalized patients with COVID-19 pneumonia and cytokine release syndrome (CRS)
November 06, 2020 01:15 ET
|
Novartis International AG
The Phase III trial investigating canakinumab plus standard of care (SoC) did not meet its primary endpoint of a greater chance of patient survival without the need for invasive mechanical...
Novartis Cosentyx® shows early synovitis reduction in patients with psoriatic arthritis in first-of-its-kind study
November 05, 2020 01:15 ET
|
Novartis International AG
Significant reduction of synovitis (joint lining inflammation) was demonstrated with Cosentyx® at Week 12 vs. placebo, with improvements as early as Week 11 ULTIMATE is the first ever Phase IIIb...
Global Cell Based Assay & High Content Screening Market Report 2020-2024
October 12, 2020 09:04 ET
|
Research and Markets
Dublin, Oct. 12, 2020 (GLOBE NEWSWIRE) -- The "Cell Based Assay & High Content Screening Markets Market Forecasts by Application, With Executive and Consultant Guides and including Customized...
Global Scientific Research and Development Services Global Market Forecast to Grow to From $802.2 billion in 2019 to $814.9 billion in 2020 at a CAGR of 1.6%
September 11, 2020 05:33 ET
|
Research and Markets
Dublin, Sept. 11, 2020 (GLOBE NEWSWIRE) -- The "Scientific Research And Development Services Global Market Report 2020-30: Covid 19 Impact and Recovery" report has been added to...
Novartis Cosentyx® receives FDA approval for new indication to treat active non-radiographic axial spondyloarthritis
June 16, 2020 19:13 ET
|
Novartis International AG
FDA approval for Cosentyx® is based on the Phase III PREVENT trial, demonstrating efficacy in active non-radiographic axial spondyloarthritis (nr-axSpA), which is part of the axial spondyloarthritis...
Novartis to sponsor large clinical trial of hydroxychloroquine in hospitalized COVID-19 patients
April 20, 2020 01:32 ET
|
Novartis International AG
Novartis has reached an agreement with the US Food and Drug Administration (FDA) to proceed with a Phase III clinical trial of hydroxychloroquine in hospitalized patients with COVID-19 disease Trial...
Brookhaven Lab Mobilizes Resources in Fight Against COVID-19
April 17, 2020 10:29 ET
|
Brookhaven National Laboratory
UPTON, NY, April 17, 2020 (GLOBE NEWSWIRE) -- Scientists and staff at the U.S. Department of Energy's (DOE) national laboratories are marshalling their expertise, unique facilities, and other key...
Novartis and life sciences companies commit expertise and assets to the fight against COVID-19 pandemic alongside Bill & Melinda Gates Foundation
March 26, 2020 02:15 ET
|
Novartis International AG
Collaboration to address product development and scale up challenges posed by current pandemic Basel, March 26, 2020 — Today, Novartis and a consortium of life sciences companies announced an...
The Austrian Alpine state combining natural beauty with a high-tech economy
January 03, 2020 05:00 ET
|
The New Economy
LONDON, Jan. 03, 2020 (GLOBE NEWSWIRE) -- The Austrian state of Carinthia may be best known for its crystal clear Alpine lakes and awe-inspiring mountains, but it is fast gaining in importance as a...
New Eye Tracking Glasses Bring Real-world Data to Academic Research
January 02, 2020 09:00 ET
|
BIOPAC Systems, Inc.
GOLETA, Calif., Jan. 02, 2020 (GLOBE NEWSWIRE) -- BIOPAC Systems, Inc. announced a new eye tracking integration for researchers who conduct experiments from mobile participants in diverse locations....